EU H2020 Project "MAGTEST (MAGTEST: Simple and specific next generation lab-on-a-chip in-vitro molecular..)": description, partecipants, costs and EC-fundings

#	Pagina
attuale pagina	/open-h2020/projects/205116/index.html
-1	/open-fp7/projects/89582/index.html
-2	/open-h2020/projects/221896/index.html
-3	/open-fp7/projects/87996/index.html
-4	/open-h2020/projects/214190/index.html
-5	/open-consip/fornitori/2021/profilo-01477730897/index.html
-6	/open-h2020/projects/198723/index.html
-7	/open-h2020/projects/227203/index.html
-8	/open-h2020/projects/227534/index.html

MAGTEST project word cloud

Explore the words cloud of the MAGTEST project. It provides you a very rough idea of what is the project "MAGTEST" about.

fundamental human 2017 identification introduction vitro gland too line devastating device judicious 8 6bn industry bulky status company boost margins kansas commercialization initially mammary worth animal 07 dna annual milk antimicrobial mastitis efficient parallel resistances city forum producers world investment market magtest health validated businesses deployment expressed solutions detection fast 2bn portable accurate biotechnology substrate bacteria bovine disease farms operate danger winning competitiveness compact 2013 industrialization clear ipr either molecular 2018 2015 industrial infection simply hindrances alone smeinst diagnostics antibiotics innovation 2016 cows pipeline award site dairy time regards detect convenient economic significantly strategy treatments informative crushing bacterial proprietary reducing sustainable first magnomics diagnostic platform till tool

Project "MAGTEST" data sheet

The following table provides information about the project.

Coordinator	MAGNOMICS SA Organization address address: PARQUE TECNOLOGICO DE CANTANHEDE NUCLEO 04 LOTE 2 city: CANTANHEDE postcode: 3060 197 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Portugal [PT]
Project website	http://www.magnomics.pt
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.2.4. (Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy) 2. H2020-EU.3.2.1. (Sustainable agriculture and forestry) 3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 4. H2020-EU.3.2.2. (Sustainable and competitive agri-food sector for a safe and healthy diet)
Code Call	H2020-SMEINST-1-2016-2017
Funding Scheme	SME-1
Starting year	2016
Duration (year-month-day)	from 2016-08-01 to 2017-01-31

#	participants	country	role	EC contrib. [€]
1	MAGNOMICS SA	PT (CANTANHEDE)	coordinator	50˙000.00

MAGNOMICS SA

PT (CANTANHEDE)

coordinator

50˙000.00

Project objective

Antimicrobial resistances are a clear and present danger for human health. More than ever, it is fundamental to have an accurate and fast bacteria identification tool to ensure the judicious deployment of antibiotics.

Current diagnostic solutions are either too complex and bulky to operate “on site”, or are simply not informative enough. Magnomics novel, fast, award winning proprietary technology is able to detect bacterial DNA using a simple, compact platform. This fully portable, easy to use in-vitro molecular diagnostic device addresses the concerns expressed by the European Commission with regards to antimicrobial resistances: it allows for the easy and convenient detection of bacteria in any substrate, significantly reducing the lead time for treatments.

In line with the expected impact of the “SMEInst-07-2016-2017” topic, Magnomics will initially focus on animal health diagnostics. This choice of market, worth €2.6bn in 2013 with an 8% growth estimated till 2018, was fully validated after winning the Innovation Award at the Kansas City Animal Health Investment Forum in 2015. Addressing a devastating disease in dairy farms across the world that is crushing the margins of milk producers in the EU, the first product will target bovine mastitis, an infection of the mammary gland of dairy cows with an annual economic impact of over €2bn in the EU alone.

This technology is expected to significantly boost the competitiveness of the dairy industry through the reduction of health-related hindrances to production. In parallel, the milk production businesses will become more sustainable through the introduction of a high-end biotechnology process within their industrial pipeline, ensuring the efficient use of resources. MAGTEST will allow the company to fully assess the market potential, IPR status of Magnomics’ technology, ensuring an effective industrialization and commercialization strategy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MAGTEST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MAGTEST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.2.4.;H2020-EU.3.2.1.;H2020-EU.2.3.1.;H2020-EU.3.2.2.)